JPH0357119B2 - - Google Patents

Info

Publication number
JPH0357119B2
JPH0357119B2 JP59149784A JP14978484A JPH0357119B2 JP H0357119 B2 JPH0357119 B2 JP H0357119B2 JP 59149784 A JP59149784 A JP 59149784A JP 14978484 A JP14978484 A JP 14978484A JP H0357119 B2 JPH0357119 B2 JP H0357119B2
Authority
JP
Japan
Prior art keywords
insulin
derivatives
proinsulin
amino acid
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59149784A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6042397A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS6042397A publication Critical patent/JPS6042397A/ja
Publication of JPH0357119B2 publication Critical patent/JPH0357119B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C07K14/622—Insulins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP59149784A 1983-07-22 1984-07-20 新規なインシユリン誘導体およびそれらの製造法 Granted JPS6042397A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833326472 DE3326472A1 (de) 1983-07-22 1983-07-22 Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326472.4 1983-07-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP1040427A Division JPH01294634A (ja) 1983-07-22 1989-02-22 糖尿病治療用医薬

Publications (2)

Publication Number Publication Date
JPS6042397A JPS6042397A (ja) 1985-03-06
JPH0357119B2 true JPH0357119B2 (enExample) 1991-08-30

Family

ID=6204660

Family Applications (2)

Application Number Title Priority Date Filing Date
JP59149784A Granted JPS6042397A (ja) 1983-07-22 1984-07-20 新規なインシユリン誘導体およびそれらの製造法
JP1040427A Granted JPH01294634A (ja) 1983-07-22 1989-02-22 糖尿病治療用医薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP1040427A Granted JPH01294634A (ja) 1983-07-22 1989-02-22 糖尿病治療用医薬

Country Status (20)

Country Link
US (1) US4701440A (enExample)
EP (1) EP0132770B1 (enExample)
JP (2) JPS6042397A (enExample)
AR (1) AR241864A1 (enExample)
AT (1) ATE29729T1 (enExample)
AU (1) AU569097B2 (enExample)
CA (1) CA1246548A (enExample)
DE (2) DE3326472A1 (enExample)
DK (2) DK172211B1 (enExample)
ES (2) ES534487A0 (enExample)
FI (1) FI79854C (enExample)
GR (1) GR81551B (enExample)
HU (1) HUT37805A (enExample)
IE (1) IE57709B1 (enExample)
IL (1) IL72469A (enExample)
NO (1) NO167810C (enExample)
NZ (1) NZ208959A (enExample)
PH (1) PH23014A (enExample)
PT (1) PT78940A (enExample)
ZA (1) ZA845620B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
WO1990007522A1 (en) * 1988-12-23 1990-07-12 Novo Nordisk A/S Human insulin analogues
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
WO1992010284A2 (en) 1990-12-07 1992-06-25 Cnc Development, Inc. Catalytic chemical reactor
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
ZA928916B (en) * 1991-11-26 1994-05-18 Lilly Co Eli Tri-arginine insulins
ES2137937T3 (es) * 1991-11-29 2000-01-01 Hoechst Ag Peptidos con efecto del tipo de insulina.
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
EP0821006B1 (de) 1996-07-26 2004-04-21 Aventis Pharma Deutschland GmbH Insulinderivate mit erhöhter Zinkbindung
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
JP4969002B2 (ja) 1999-06-08 2012-07-04 ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン ｒＡＡＶ形質導入を増加するための化合物および方法
US6852694B2 (en) 2001-02-21 2005-02-08 Medtronic Minimed, Inc. Stabilized insulin formulations
CN1177920C (zh) * 2001-02-21 2004-12-01 株式会社正和·专门 附着于钛材上的水垢的去除剂
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
EP1608410A2 (en) 2003-03-31 2005-12-28 University of Iowa Research Foundation Pharmico-gene theraphy of epithelial sodium channel associated disoders
EP2316844A3 (en) * 2003-05-21 2011-07-20 Biotech Tools S.A. Peptide complex
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
KR101915454B1 (ko) 2009-11-13 2018-11-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
LT2554183T (lt) 2009-11-13 2018-07-25 Sanofi-Aventis Deutschland Gmbh Farmacinė kompozicija, apimanti glp-1-agonistą, insuliną ir metioniną
HRP20161620T1 (hr) 2010-08-30 2017-01-13 Sanofi-Aventis Deutschland Gmbh Uporaba ave0010 za proizvodnju lijeka za liječenje dijabetes melitusa tip 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
DK2750699T3 (en) 2011-08-29 2015-10-26 Sanofi Aventis Deutschland A pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
HUE062573T2 (hu) 2014-12-12 2023-11-28 Sanofi Aventis Deutschland Glargin inzulin/lixiszenatid rögzített arányú készítmény
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
AU2017229347A1 (en) 2016-03-07 2018-11-01 University Of Iowa Research Foundation AAV-mediated expression using a synthetic promoter and enhancer
WO2017205739A1 (en) 2016-05-26 2017-11-30 University Of Iowa Research Foundation cis AND trans REQUIREMENTS FOR TERMINAL RESOLUTION OF HUMAN BOCAVIRUS 1
US11142775B2 (en) 2017-01-13 2021-10-12 University Of Iowa Research Foundation Bocaparvovirus small noncoding RNA and uses thereof
JP7439062B2 (ja) 2018-09-19 2024-02-27 ノヴォ・ノルディスク・リサーチ・センター・オックスフォード・リミテッド グルコース感受性インスリンおよびその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2256215C3 (de) * 1972-11-16 1981-01-08 Hoechst Ag, 6000 Frankfurt Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin
DE2460753A1 (de) * 1974-12-21 1976-06-24 Hoechst Ag Verfahren zur herstellung von humaninsulin
DK146482C (da) * 1979-04-13 1986-10-06 Shionogi & Co Fremgangsmaade til fremstilling af et b30-threonin-insulin
DK319780A (da) * 1980-07-24 1982-01-25 Forenede Bryggerier As Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
NL8201650A (nl) * 1982-04-21 1983-11-16 Akzo Nv Semisynthetische bereiding van humane insuline.
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE3334407A1 (de) * 1983-09-23 1985-04-04 Hoechst Ag, 6230 Frankfurt In position b 30 modifizierte insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
JPH118546A (ja) * 1997-04-24 1999-01-12 Hitachi Ltd Ｃｍｏｓ回路

Also Published As

Publication number Publication date
ZA845620B (en) 1985-02-27
EP0132770A1 (de) 1985-02-13
ES8505646A1 (es) 1985-06-01
JPS6042397A (ja) 1985-03-06
JPH052654B2 (enExample) 1993-01-13
ATE29729T1 (de) 1987-10-15
EP0132770B1 (de) 1987-09-16
DK1790D0 (da) 1990-01-04
US4701440A (en) 1987-10-20
PT78940A (de) 1984-08-01
IL72469A (en) 1989-07-31
JPH01294634A (ja) 1989-11-28
AU569097B2 (en) 1988-01-21
NO167810C (no) 1991-12-18
PH23014A (en) 1989-03-03
AR241864A1 (es) 1993-01-29
ES8504678A1 (es) 1985-04-16
FI842914L (fi) 1985-01-23
DK172211B1 (da) 1998-01-05
DK358284D0 (da) 1984-07-20
IE841889L (en) 1985-01-22
NO842977L (no) 1985-01-23
GR81551B (enExample) 1984-12-11
DK1790A (da) 1990-01-04
FI842914A0 (fi) 1984-07-19
ES535706A0 (es) 1985-06-01
ES534487A0 (es) 1985-04-16
CA1246548A (en) 1988-12-13
IE57709B1 (en) 1993-03-10
FI79854C (fi) 1990-03-12
DE3466227D1 (en) 1987-10-22
DE3326472A1 (de) 1985-02-14
IL72469A0 (en) 1984-11-30
AU3092284A (en) 1985-01-24
DK172209B1 (da) 1998-01-05
NZ208959A (en) 1989-02-24
NO167810B (no) 1991-09-02
HUT37805A (en) 1986-02-28
FI79854B (fi) 1989-11-30
DK358284A (da) 1985-01-23

Similar Documents

Publication Publication Date Title
JPH0357119B2 (enExample)
US6908897B2 (en) Covalently bridged insulin dimers
US4608364A (en) Pharmaceutical agent for the treatment of diabetes mellitus
CA1246478A (en) Process for the preparation of insulin derivatives, the b chain of which is lengthened c-terminally, novel insulin derivatives modified by bases, agents containing these derivatives and their use
US4581165A (en) Anti-diabetic compounds
US5698669A (en) Tri-arginine insulins
EP0194864A2 (en) Novel peptides
US5149716A (en) Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them
EP0382732A1 (en) SUPERACTIVE HUMAN INSULIN ANALOGS.
EP0171147B1 (en) Anti-diabetic compounds
DK172632B1 (da) Lægemiddel til behandling af diabetes mellitus og anvendelse af insulinderivater til fremstilling af et sådant lægemiddel
KR920005659B1 (ko) 인슐린 유도체의 제조방법
CA1338584C (en) Superactive human insulin analogues
JPH0150718B2 (enExample)